Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Reflect ScientificRSCF +6.26% Return-on-Tangible-Asset is 6.38% as of Sep. 2025. The stock has 4 warning signs investors should review. Among 856 Medical Devices & Instruments companies, Reflect Scientific ranks better than 52.45% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Reflect Scientific's annualizedNet Income for the quarter that ended in Sep. 2025 was $0.16 Mil. Reflect Scientific's average total tangible assets for the quarter that ended in Sep. 2025 was $2.57 Mil. Therefore, Reflect Scientific's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2025 was 6.38%.
The historical rank and industry rank for Reflect Scientific's Return-on-Tangible-Asset or its related term are showing as below:
RSCF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -114.11 Med: -21.82 Max: 120.29
Current: 1.42
During the past 13 years, Reflect Scientific's highest Return-on-Tangible-Asset was 120.29%. The lowest was -114.11%. And the median was -21.82%.
RSCF's Return-on-Tangible-Asset is ranked better than 52.45% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.595
vs RSCF: 1.42
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Reflect Scientific Return-on-Tangible-Asset Related Terms
Reflect Scientific Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Reflect Scientific's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RSCF vs NXGL, LUCY, GCTK: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Reflect Scientific's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Sep. 2025) net income data.
What does a Return-on-Tangible-Asset of 6.38% mean?
Reflect Scientific (RSCF) has a Return-on-Tangible-Asset of 6.38% as of Sep. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Reflect Scientific and its competitors. According to the industry distribution chart, Reflect Scientific ranks #407 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 47.5%.
Is Reflect Scientific's Return-on-Tangible-Asset too high?
Reflect Scientific's current Return-on-Tangible-Asset is 6.38%. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.60. Reflect Scientific's value of 6.38% is 972.3% above this industry median. Based on the distribution chart, Reflect Scientific ranks #407 out of 856 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Reflect Scientific's Return-on-Tangible-Asset compare to NXGL and LUCY?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #407 out of 856 companies for Return-on-Tangible-Asset. This puts Reflect Scientific in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.60. Reflect Scientific's value of 6.38% is 972.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.60, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current Return-on-Tangible-Asset of 6.38% is 972.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Reflect Scientific and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current Return-on-Tangible-Asset is 6.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current Return-on-Tangible-Asset of 6.38%. The current Return-on-Tangible-Asset is 6.38% and 972.3% above the Medical Devices & Instruments industry median of 0.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current Return-on-Tangible-Asset is 6.38% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 
